MEIS1 and Ewing sarcoma: Among these 147 super-enhancer-associated transcripts, we were particularly interested in MEIS1, because the intensity of its super-enhancer ranked first in SKNMC cells (Figure 3A), and it had prominent expression profiles in Ewing sarcoma (Figure 4C).